Elabscience
SKU:E-AB-F1086G
PE/Cyanine5 Anti-Human CD9 Antibody[HI9a]
PE/Cyanine5 Anti-Human CD9 Antibody[HI9a]
Couldn't load pickup availability
PE/Cyanine5 Anti-Human CD9 Antibody[HI9a]
The PE/Cyanine5 Anti-Human CD9 Antibody [HI9A] is a highly specific and reliable tool designed for the detection and analysis of CD9 expression in human samples. This antibody is conjugated with PE/Cyanine5, a fluorochrome that provides excellent brightness and stability, ensuring accurate and consistent results.
CD9, a member of the tetraspanin family, is a cell surface glycoprotein involved in various cellular processes, including cell adhesion, migration, and signal transduction. It is widely expressed in different cell types, making it a valuable marker for the identification and characterization of various cell populations.
The PE/Cyanine5 Anti-Human CD9 Antibody [HI9A] exhibits exceptional specificity, binding only to the CD9 antigen without cross-reactivity to other related molecules. This feature guarantees reliable and precise detection of CD9 expression in human samples, enabling researchers to obtain high-quality data for their studies.
This antibody is optimized for flow cytometry applications, allowing for the analysis of large cell populations with high sensitivity and accuracy. Its PE/Cyanine5 conjugation ensures bright and distinct staining, facilitating the identification and sorting of CD9-positive cells.
Furthermore, the PE/Cyanine5 Anti-Human CD9 Antibody [HI9A] is manufactured under strict quality control standards, ensuring batch-to-batch consistency and reproducibility. It is supplied in a convenient format, ready-to-use for immediate application in research laboratories and clinical settings.
In summary, the PE/Cyanine5 Anti-Human CD9 Antibody [HI9A] is a reliable and specific tool for the detection and analysis of CD9 expression in human samples. Its exceptional performance in flow cytometry applications, coupled with its bright and stable fluorochrome conjugation, makes it an ideal choice for researchers and clinicians seeking accurate and reproducible results in their studies.
Share
